MORONI, ELISABETTA MARIA
 Distribuzione geografica
Continente #
AS - Asia 1.198
NA - Nord America 590
EU - Europa 330
SA - Sud America 283
AF - Africa 21
OC - Oceania 2
Totale 2.424
Nazione #
US - Stati Uniti d'America 563
SG - Singapore 530
CN - Cina 249
BR - Brasile 229
IT - Italia 164
HK - Hong Kong 154
VN - Vietnam 102
KR - Corea 53
FI - Finlandia 37
IN - India 32
NL - Olanda 30
AR - Argentina 27
DE - Germania 22
GB - Regno Unito 17
FR - Francia 14
MX - Messico 12
JP - Giappone 11
IL - Israele 9
ZA - Sudafrica 9
ID - Indonesia 8
BD - Bangladesh 7
CO - Colombia 7
AT - Austria 5
CA - Canada 5
EC - Ecuador 5
ES - Italia 5
PE - Perù 5
PK - Pakistan 5
PL - Polonia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CL - Cile 4
IQ - Iraq 4
RU - Federazione Russa 4
SA - Arabia Saudita 4
TR - Turchia 4
UZ - Uzbekistan 4
BB - Barbados 3
NP - Nepal 3
PY - Paraguay 3
SE - Svezia 3
TN - Tunisia 3
UA - Ucraina 3
BE - Belgio 2
CZ - Repubblica Ceca 2
EG - Egitto 2
IE - Irlanda 2
JM - Giamaica 2
KE - Kenya 2
LK - Sri Lanka 2
LV - Lettonia 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MF - Saint Martin 1
MK - Macedonia 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
UY - Uruguay 1
VE - Venezuela 1
Totale 2.424
Città #
Singapore 315
Santa Clara 311
Hong Kong 154
Hefei 130
Milan 58
Beijing 55
Ashburn 53
Seoul 53
Ho Chi Minh City 33
Dallas 31
Hanoi 23
Lappeenranta 23
Los Angeles 21
São Paulo 15
Brescia 12
Rio de Janeiro 11
Alzano Lombardo 10
Mumbai 10
Johannesburg 8
Minamishinagawa 8
Helsinki 7
New York 7
Padova 7
San Jose 7
Trieste 7
Turku 7
Frankfurt am Main 6
Nuremberg 6
Belo Horizonte 5
Buffalo 5
Campinas 5
Chennai 5
Curitiba 5
Da Nang 5
Bengaluru 4
Brasília 4
Brooklyn 4
Chicago 4
Cirimido 4
Colombo 4
Falkenstein 4
Guarulhos 4
Houston 4
Hải Dương 4
Lima 4
Mexico City 4
Pelotas 4
Porto Alegre 4
Tashkent 4
Warsaw 4
Amsterdam 3
Bergamo 3
Biên Hòa 3
Bridgetown 3
Buenos Aires 3
Denver 3
Dhaka 3
Florence 3
Haiphong 3
Lauterbourg 3
London 3
Manaus 3
Montreal 3
Ninh Bình 3
Quito 3
Quận Một 3
Riyadh 3
San Francisco 3
Scandicci 3
Sorrento 3
Tokyo 3
Vienna 3
Aracaju 2
Atlanta 2
Blumenau 2
Bogotá 2
Boston 2
Brussels 2
Can Tho 2
Canoas 2
Caxias do Sul 2
Ciudad del Este 2
Düsseldorf 2
Florianópolis 2
Fortaleza 2
Ha Long 2
Ipatinga 2
Jakarta 2
Juiz de Fora 2
Kingston 2
Kolkata 2
Lages 2
Lahore 2
Munich 2
Nairobi 2
Novara 2
Novo Hamburgo 2
Olomouc 2
Orem 2
Ourinhos 2
Totale 1.604
Nome #
Design and Test of Molecules that Interfere with the Recognition Mechanisms between the SARS-CoV-2 Spike Protein and Its Host Cell Receptors 97
Frontiers and Challenges of Computing ncRNAs Biogenesis, Function and Modulation 73
Conformational Dynamics of hAgo2 Silencing: Decoding Functional Divergence across Human Argonaute Paralogs 69
Target oriented-drug discovery: unraveling the molecular interaction between Leishmania Hsp90 and a celastrol carboxamide derivative 60
Design of allosteric stimulators of the HSP90 ATPase as novel anticancer leads 58
The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations May Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein 57
Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design 56
Point mutations of the mitochondrial chaperone TRAP1 affect its functions and pro-neoplastic activity 54
HIF1alfa-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia 54
Insights from molecular dynamics simulations for the development of modulators of mitochondrial Hsp90 (Trap1) activity 53
Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1 52
N-Glycosylation-Induced Pathologic Protein Conformations as a Tool to Guide the Selection of Biologically Active Small Molecules 51
Visualizing the Dynamics of a Protein Folding Machinery: The Mechanism of Asymmetric ATP Processing in Hsp90 and its Implications for Client Remodelling 50
Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1 50
Transcription factor protein interactomes reveal genetic determinants in heart disease 48
Integrating Protein Interaction Surface Prediction with a Fragment-Based Drug Design: Automatic Design of New Leads with Fragments on Energy Surfaces 47
Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1 44
How aberrant N-glycosylation can alter protein functionality and ligand binding: An atomistic view 43
Investigating Dynamic and Energetic Determinants of Protein Nucleic Acid Recognition: Analysis of the Zinc Finger Zif268-DNA Complexes 41
Editorial: Computational drug discovery for targeting of protein-protein interfaces—Volume II 41
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 41
N-Glycosylation as a Modulator of Protein Conformation and Assembly in Disease 37
Studying the Dynamics of a Complex G-Quadruplex System: Insights into the Comparison of MD and NMR Data 37
Allosteric Regulation Points Control the Conformational Dynamics of the Molecular Chaperone Hsp90 37
Design and synthesis of cyclic peptides targeting Gas6 36
The Dynamics of the Folding Machinery 35
Machine Learning Prediction of Allosteric Drug Activity from Molecular Dynamics 35
Expedient Access to 2-Benzazepines by Palladium-Catalyzed C-H Activation: Identification of a Unique Hsp90 Inhibitor Scaffold 34
Protein Allostery and Ligand Design: Computational Design Meets Experiments to Discover Novel Chemical Probes 34
Advancing Molecular Simulations: Merging Physical Models, Experiments, and AI to Tackle Multiscale Complexity 33
Disulfide-mediated tetramerization of TRAP1 fosters its antioxidant and pro-neoplastic activities 32
Structural determinants of cold activity and glucose tolerance of a family 1 glycoside hydrolase (GH1) from Antarctic Marinomonas sp. ef1 32
Atomistic Simulations of the Mechanisms of the Poorly Catalytic Mitochondrial Chaperone Trap1: Insights into the Effects of Structural Asymmetry on Reactivity 32
SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern 31
Conformational Behavior of SARS-Cov-2 Spike Protein Variants: Evolutionary Jumps in Sequence Reverberate in Structural Dynamic Differences 30
Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors 29
Targeting the mitochondrial chaperone TRAP1: strategies and therapeutic perspectives 29
Molecular structure and enzymatic mechanism of the human collagen hydroxylysine galactosyltransferase GLT25D1/COLGALT1 28
Novel PARP-1 Inhibitor scaffolds disclosed by a dynamic structure-based pharmacophore approach 27
molecular dynamics simulations reveal the mechanisms of allosteric activation of Hsp90 by designed ligands 27
A Fe2+-dependent self-inhibited state influences the druggability of human collagen lysyl hydroxylase (LH/PLOD) enzymes 27
A NMR and computational study of Smac mimics targeting both the BIR2 and BIR3 domains in XIAP protein 26
Cracking the chaperone code through the computational microscope 26
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors 26
Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization. 26
Structures, dynamics, complexes, and functions: From classic computation to artificial intelligence 26
Dynamic-based discovery of new allosteric ligands targeting the Hsp90 C-terminal inhibitor binding site 25
Exploiting conformational dynamics in drug discovery: Design of C-terminal inhibitors of Hsp90 with improved activities 25
The Structural Asymmetry of Mitochondrial Hsp90 (Trap1) Determines Fine Tuning of Functional Dynamics 25
MM/PBSA analysis of molecular dynamics simulations of bovine beta-lactoglobulin: free energy gradients in conformational transitions? 24
Evaluation of docking procedures reliability in affitins-partners interactions 24
The Dynamics of Drug Discovery 24
Investigating dynamic and energetic determinants of protein nucleic acid recognition: Analysis of the zinc finger zif268-DNA complexes 23
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 23
Impact of Mutations on NPAC Structural Dynamics: Mechanistic Insights from MD Simulations 22
Second generation of fucose-based DC-SIGN ligands: Affinity improvement and specificity versus Langerin 22
Synthesis of Functionalized 2-(4-Hydroxyphenyl)-3-methylbenzofuran Allosteric Modulators of Hsp90 Activity 22
Arrestins as Possible Drug Targets 22
Identification of DNA-binding protein target sequences by physical effective energy functions: Free energy analysis of lambda repressor-DNA complexes 22
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 22
Conformational regulation of Hsp90 though mutations and small molecules 22
Assessment of Mutational Effects on Peptide Stability through Confinement Simulations 22
Conformational regulation of Hsp90 through mutation and small molecules 22
A Molecular Dynamics Study of the Interaction of D-Peptide Amyloid Inhibitors with Their Target Sequence Reveals a Potential Inhibitory Pharmacophore Conformation 22
Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography 21
A Molecular Dynamics Study of the Interaction of D-Peptide Amyloid Inhibitors with Their Target Sequence Reveals a Potential Inhibitory Pharmacophore Conformation 21
Computational approaches meet experiments to design new allosteric ligands 20
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy 20
Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors 20
Molecular dynamics simulations of hsp90 with an eye to inhibitor design. 19
Using QM/MM Molecular Dynamics to Model Reactivity in the mitochondrial Chaperone Trap1 19
Chemical and Biophysical Approaches to Allosteric Modulation 19
Identification of a new scaffold for Hsp90 C-terminal inhibition 19
3D-QSAR-Assisted Design, Synthesis, and Evaluation of Novobiocin Analogues 18
Modifying Hsp90 dynamics and functional relationships through rationally designed allosteric activators 18
Structure and sequence determinants of aggregation investigated with molecular dynamics 17
Activation of Hsp90 activity and conformational dynamics through computationally designed allosteric ligands: functional implications 17
Structure and sequence determinants of aggregation investigated with molecular dynamics 14
Totale 2.586
Categoria #
all - tutte 8.860
article - articoli 7.735
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.595


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202413 0 0 0 0 0 0 0 0 1 2 0 10
2024/20251.405 2 3 70 54 250 201 43 117 31 66 298 270
2025/20261.168 108 172 196 290 328 62 12 0 0 0 0 0
Totale 2.586